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Abstract Polycystin-L (PCL) shares high homology with
polycystin-2, the product of polycystic kidney disease gene-2. It
was previously shown that the PCL forms a non-selective cation
channel activated by calcium influx. However, it remains unclear
whether calcium activates/inactivates PCL by binding to the EF-
hand motif located on the cytoplasmic carboxyl-terminus. Here
we obtained two PCL splice variants from liver (PCL-LV,
lacking the EF-hand) and testis (PCL-TS, lacking 45 amino
acids on the carboxyl tail) using PCR-based approaches. When
expressed in Xenopus oocytes and studied using electrophysiol-
ogy both splice variants exhibited basal cation channel activity
and calcium-induced channel activation. While PCL-TS dis-
played similar activation to PCL, PCL-LV exhibited a three-
fold increased activation. All five PCL C-terminal artificial
truncation mutants also exhibited basal and calcium-activated
channel activities, in particular the mutant T622X lacking the
EF-hand was associated with increased activation. Our data
demonstrate that the EF-hand and other parts of the carboxyl
tail of PCL are not determinants of channel activation/
inactivation although the EF-hand seems to be involved in the
modulation of these processes. ß 2002 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Autosomal dominant polycystic kidney disease (ADPKD)
is a frequent genetic disorder that occurs in about 0.1% of the
population worldwide. Cysts in ADPKD develop from dila-
tion of any part of the nephron and the early stages of the
disease are characterized by thickening and disorganization of
the basement membrane. ADPKD also manifests extrarenal
cysts in liver, pancreas, spleen and central nervous system,
and results in gastrointestinal and cardiovascular abnormal-
ities [1]. Abnormal £uid secretion, hyperproliferation of tub-
ular epithelial cells, altered ion transport properties, and mis-
targeting of normally polarized membrane proteins such as
Na^K ATPase are also associated with ADPKD [2^4].
About 95% of ADPKD are associated with mutations in ei-
ther the PKD1 (accession number: U24497) [5] encoding poly-
cystin-1 or PKD2 (U50928) [6] encoding polycystin-2 (PC2)
and possibly one or more genes accounting for the other 5%
of ADPKD remain to be identi¢ed. New members of the
ADPKD family have recently been identi¢ed, including
PKDL (AF073481) [7] encoding polycystin-L1 (PCL) [8],
PKD2L2 (NM_014386) [9,10] encoding PC2L2, PKDREJ
(AF116458) [11], and PKD1L1 [12]. Polycystin homologues
have also been identi¢ed from sea urchin sperm [13], Caeno-
rhabditis elegans [14] and Drosophila [15]. Although these new
members are unlikely to be associated with ADPKD, some
are involved in mating or fertilization [13,14]. It is thus im-
portant to understand their functions and regulations at the
molecular level in order to elucidate mechanisms underlying
their di¡erent physiological roles.
PC2, -L, and -2L2 exhibit similar membrane topologies as
well as modest sequence homology to the K-subunits of vol-
tage-gated Na, K and Ca2 channels and transient receptor
potential family channels [16^18]. PCL was recently shown to
be a calcium-regulated, calcium-permeable non-selective ion
channel [19]. PC2 was later demonstrated to be a cation chan-
nel as well [20^22], with functional characteristics similar to
but distinct from PCL. A pathogenic C-terminal truncation
mutant of PC2, R742X, was also found to have cation chan-
nel activity but with altered membrane targeting [23]. Since
the cytoplasmic C-terminus of PCL (D562^S805) contains
several motifs such as a Ca2-binding EF-hand, coiled-coil
structure and phosphorylation sites, this region might be im-
portant for the function and regulation of PCL. Also, several
recently identi¢ed splice variants of PCL correspond to dele-
tion mutations in this region. Alternative splicing is also seen
in other cation channels with a similar structure and sequence
to PCL [24^26]. Through functional studies of such splice
variants and arti¢cial mutants, roles of some important do-
mains may be elucidated, which will be helpful to the further
understanding of the molecular functions of PCL and PC2. In
particular, the roles of the EF-hand motif in these two poly-
cystin channels are still unclear. According to previous re-
ports, this motif in voltage-gated cation channels may [27^
29] or may not [30] be involved in channel inactivation.
In the present study, we obtained two naturally occurring
splice variants of PCL using PCR-based cloning and con-
structed a number of arti¢cial PCL mutants truncated at dif-
ferent sites in the cytoplasmic C-terminal tail using site-di-
rected mutagenesis. Functional studies using electrophys-
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iology and Xenopus oocyte expression system were performed
to elucidate the role of the C-terminus and particularly that of
the EF-hand with respect to calcium-induced activation and
the ensuing channel inactivation.
2. Materials and methods
2.1. Molecular biology
Human PKDL cDNA ampli¢cation was performed using kidney,
liver, brain and heart Matchmaker libraries, Marathon-Ready1 testis
cDNA, and liver poly(A) RNA (Clontech, Palo Alto, CA, USA).
The forward primer 5P-ATCGTCTAGATCACCATGAATGCTGT-
GGGAAGTCC and the reverse primer 5P-ATCGAGATCTCTCCG-
GGAGTGCCTCACACTTA were used to amplify the PKDL cDNA
(AF073481) [7] fragment spanning the translational start and termi-
nation code. The PCR product was ligated to the pTLN2 vector [31],
a generous gift of Drs. Jentsch and Fong, for expression in Xenopus
oocytes. For ampli¢cation of a PKDL 3P fragment (T1683^G2435),
the following pair of primers was used: 5P-TGACACATATTCAGA-
GGTCAAG and 5P-CCGGGAGTGCCTCACACTTA. Truncation
mutants of the kidney PCL (T622X, V670X, G692X, and R740X,
see Fig. 1C) were obtained by introducing a stop codon at speci¢ed
sites to the human kidney PKDL cDNA inserted in the pTLN2 vector
using the QuickChange1 kit (Stratagene, La Jolla, CA, USA). All
mutations were con¢rmed by sequencing.
2.2. Oocyte preparation
Capped synthetic RNAs were in vitro transcribed from linearized
templates using the mMESSAGE mMACHINE1 Kit (Ambion, Aus-
tin, TX, USA). H2O (50 nl) alone or containing 25^50 ng mRNA was
injected into Xenopus oocytes prepared similarly as before [32].
Brie£y, oocytes were extracted from stage V^VI Xenopus laevis and
were defolliculated using a Ca2-free solution (in mM, 90 NaCl,
2 KCl, 0.82 MgSO4, 10 HEPES, pH 7.5) containing 2 mg/ml collage-
nase for 2^2.5 h at V22‡C. Injected oocytes were incubated at 18‡C
in the Barth’s solution containing: 90 NaCl, 2 KCl, 0.82 MgSO4, 0.41
CaCl2, 0.33 Ca(NO3)2 10 HEPES, pH 7.5, supplemented with anti-
biotics. Experiments were performed 2^4 days after injection.
2.3. Electrophysiology
Two-microelectrode voltage-clamp experiments were performed as
previously [19] using a TEV-200A ampli¢er (Dagan Corporation,
Minneapolis, MN, USA), Digidata 1320A and pClamp8 (Axon In-
struments, Foster City, CA, USA). The standard solution for these
experiments contained: 100 NaCl, 2 KCl, 1 MgCl2, 10 HEPES, pH
7.5. Patch-clamp experiments were performed as previously [19] using
a 3900A ampli¢er (Dagan), Digidata 1320A and pClamp8. Data anal-
yses were performed using Clamp¢t8, Fetchan and pStat (Axon) and
¢gures were generated using Sigmaplot5 (Jandel Scienti¢c, San Rafael,
CA, USA) and Corel Draw8 (Corel Corporation, Ottawa, ON, Can-
ada). Data were presented in the mean þ S.E.M. (n) form, where n
indicates the number of oocytes or oocyte patches tested.
2.4. 45Ca uptake measurements
45CaCl2 (Amersham Pharmacia Biotech, Baie d’Urfe, QC, Canada)
at 30 WM was added to an uptake solution (speci¢ed in ¢gure legends)
plus 1 mM non-radioactive CaCl2. Ten oocytes of each sample were
incubated in 0.5 ml of the uptake solution for 30 min and the incu-
bation was terminated by washing oocytes in the ice-cold uptake so-
lution.
3. Results
3.1. Cloning of PCL and splice variants
Human PCL exhibits tissue-speci¢c alternative splicing ac-
cording to recent reports [10,33]. To study the molecular func-
tions of splice variants and to determine functional di¡erences
among them, we used PCR-based approaches to amplify
PKDL from human kidney, liver and testis cDNA libraries.
DNA sequencing revealed an identical 5P end of PKDL coding
region (1^1921) from the three libraries. The kidney cDNA
was identical to the one previously used [19] so we named it
PKDL. The initially published sequence [7] di¡ered from the
kidney PKDL in two point mutations at the 3P end of the
coding region: C instead of T (in our kidney PKDL) at nu-
cleotide 2203 (Gln instead of Pro at amino acid 716) and A
instead of C at nucleotide 2147, with no change in amino acid
residue, presumably re£ecting single nucleotide polymor-
phisms (Fig. 1A). The liver cDNA (PKDL-LV) exhibited de-
letion within exon 12. This splicing did not totally obey the
GT/AG (donor/acceptor) rule as it was generated by an alter-
native cryptic donor CT. Similar splicing mechanisms have
previously been observed in PKD2 pathogenic mutations
[34] and in PKDL from transformed lymphoblasts [33]. This
splicing resulted in no frame shift and in missing the putative
Ca-binding EF-hand motif (29 amino acid residues E637^
L665) in PCL-LV (Fig. 1B). This splicing was con¢rmed by
reverse transcription-PCR ampli¢cation from a liver poly(A)
RNA. The testis cDNA (PKDL-TS) corresponded to deletion
of entire exon 15 and thus encoded a splice protein (PCL-TS)
shorter than the kidney PCL by 45 amino acids on the C-ter-
minus (Fig. 1B,C), which is likely to be identical to one pre-
viously identi¢ed from human transformed lymphoblasts [33].
Note that PKDL-LV and a PKDL 3P fragment (T1683^
G2435) ampli¢ed from brain and heart (data not shown) pos-
sess the same nucleotides C2147 and T2203 as the kidney
PKDL and that PKDL-TS has the same A2147 and C2203
found in the initially published sequence [7].
3.2. Basal conductance and calcium-induced channel activation
of splice variants
When the two-microelectrode voltage-clamp technique was
used to measure whole-cell currents in Xenopus oocytes ex-
pressing PCL-LV or PCL-TS, respectively, substantial perme-
ability to Na, K and Rb, but not to large cation NMDG
(N-methyl-D-glucamine), was observed in the absence of ex-
ternal Ca2 (Fig. 2A). Similar to PCL, PCL-TS was also per-
meable to the alkaline earth metals, in the order of
Sr2sBa2sMg2 (Fig. 2C). Radiotracer measurements us-
ing 45Ca demonstrated that both channels were permeable to
Ca2 (Fig. 2B). Current^voltage (I^V) curves obtained from
oocytes expressing either splice variant in the presence of the
external standard solution (100 mM NaCl) or the solution
containing 50 mM NaCl+100 mM mannitol were compared
and showed no signi¢cant di¡erence in outward current (data
not shown), demonstrating that Cl3 is not a permeant of
these two splice variants. These data indicated that, like
PCL, both PCL-LV and PCL-TS channels retained the non-
selective permeability to mono- and divalent cations.
Since PCL-LV contained no Ca2-binding EF-hand motif
in its C-terminus and PCL-TS had a shorter C-terminus com-
pared to PCL, we determined their capability of mediating
Ca2-induced activation. Addition of 5 mM Ca2 to the stan-
dard solution evoked large inward currents in oocytes voltage-
clamped at 350 mV (Fig. 3A), demonstrating that the EF-
hand is not essentially required for Ca2-induced channel ac-
tivation. This activation occurred at the whole range of mem-
brane potentials tested, as shown by the I^V curve #2 (Fig.
3B). The reversal potential (Vrev) obtained from I^V curves #2
(at activation peak) showed no substantial di¡erence for the
three isoforms and averaged 326 þ 3 mV (n = 15), which
seems to infer a major contribution from the Cl3 current.
However, when 70 mM glutamate replaced the equimolar
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Fig. 1. Sequence alignment and schematic illustration for human PCL splice variants and truncation mutants. A,B: Black areas indicate identi-
cal sequence among the three splice variants while gray areas indicate sequence mismatches. A: cDNA sequence alignment of the 3P ends of hu-
man PKDL isolated from kidney, liver and testis. The region encoding the EF-hand motif, the coiled-coil structure and those corresponding to
exons 12 and 15 are underlined by gray, dotted and black bars, respectively. B: Amino acid sequence alignment of the C-terminus (Q606^) of
PCL (kidney), PCL-LV (liver), and PCL-TS (testis). C: Top, putative membrane topology predicted for PCL based on amino acid hydropho-
bicity. Square and triangle £ags indicate PKC and PKA phosphorylation sites, respectively. ‘P’ indicates the putative pore region. Bottom, the
C-terminal fragments (N561^) of the four PCL truncation mutants and two splice variants are illustrated. The box at the end of the bar for
PCL-TS indicates the nine amino acid residues that are di¡erent from those in PCL (see B).
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amount of Cl3 in the standard solution, this Vrev averaged
320 þ 4 mV (n = 10) while the predicted Vrev value for Cl3
under this condition was about 35 mV, indicating that the
majority of the current at activation peak was not due to Cl3.
To determine whether calcium alone could also lead to acti-
vation, Na was replaced by the impermeant NMDG. Addi-
tion of 5 mM Ca2 to the NMDG-containing solution also
elicited large channel activation (Fig. 3C). In oocytes express-
ing PCL-TS pre-injected with EGTA to an estimated ¢nal
concentration of 2 mM, no Ca2-induced activation but
only a relatively small inward current (as compared with the
Na current) was observed, likely due to calcium entry (Fig.
2C). Thus, these basic functional features (basal permeability
to cations in the absence of calcium and activation by calci-
um) of the two splice channels were similar to those of PCL
reported previously [19].
We next wanted to determine whether they di¡ered in the
extent of Ca2-induced activation, assessed by the ratio of the
current in the presence of Ca2 (INaCa) to the one in the
absence of Ca2 (INa). The measured ratio (INaCa/INa) for
PCL-LV was about three-fold higher than PCL (Fig. 4). In
contrast, the ratio for PCL-TS did not signi¢cantly di¡er from
PCL. Thus, in contrast to the speculation that the EF-hand in
the intracellular C-terminus may be the Ca2-binding site for
the observed channel activation, the absence of the EF-hand
in PCL-LV substantially enhanced its activation ability by
calcium. Note that the ratio represents an intrinsic character-
istic of channel function and is independent of the expression
levels of polycystins in oocyte plasma membrane.
In an attempt to evaluate whether the two splice variants
displayed activation and inactivation kinetics distinct from the
kidney PCL, we measured the half-rising time and half-decay
time as two parameters characterizing the Ca2-induced acti-
vation and inactivation time courses, respectively. Similar
Fig. 2. Non-selective basal permeability to mono- and divalent cations. A: Left, I^V curves representative of ¢ve oocytes expressing PCL-LV in
the presence of the extracellular standard solution (‘Na’) or solutions where Na was replaced by equimolar NMDG, Rb or K. Right, I^V
curves representative of ¢ve oocytes expressing PCL-TS. Experiments were performed using the two-microelectrode voltage-clamp technique us-
ing a ramp protocol [19]. B: Calcium entry to oocytes expressing PCL or the splice variants was assessed by radiolabeled 45Ca uptake using
the NMDG-substituted solution (‘NMDG’). Presented data were averaged from three experiments. Uptake was performed at days 2 and 3, re-
spectively. Oocytes injected with PCL-LV exhibited earlier channel expression than those injected with PCL and PCL-TS (TS) and usually most
of them died or were unhealthy at day 3. ‘ND’ indicates ‘not determined’. Oocytes injected with water were used as control. C: Inward cur-
rents at 350 mV due to divalent cations (5 mM) contained in ‘NMDG’. Experiments were performed 1^3 h following the injection of 28 nL
of 50 mM EGTA into oocytes expressing PCL-TS. Assuming an e¡ective volume of 0.7 Wl for an oocyte, the ¢nal EGTA concentration was es-
timated to be 2 mM.
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half-rising and half-decay times were observed for the three
channels (Fig. 5). No voltage dependence of the two time
constants was observed when they were evaluated over the
membrane potential range between 340 and 3140 mV, sug-
gesting that activation and inactivation do not involve binding
(or dissociation) of a charged ligand such as Ca2 to (or from)
a PCL transmembrane site. The activation process was faster
than inactivation: the half-rising time was 3.8 þ 0.5- (n = 25),
3.5 þ 0.5- (n = 18) and 3.2 þ 0.5- (n = 8) fold smaller than the
half-decay time for PCL, PCL-LV and PCL-TS, respectively.
Thus, the EF-hand motif and the carboxyl tail (E752^S805) of
PCL are not responsible for the time course of activation and
the ensuing inactivation processes.
3.3. Single-channel currents of splice variants
Patch-clamp experiments revealed that PCL-LV and PCL-
TS, like PCL, exhibited large conductance to K. In a cell-
attached con¢guration with the pipette solution containing (in
mM) 110 KCl, 13 KOH, 5 HEPES, 1 EGTA, and pH 7.4,
large downward de£ating currents were observed at negative
membrane potentials in oocytes expressing PCL-LV or PCL-
TS (Fig. 6). When the slope of the I^V curves was used to
evaluate the single-channel conductance, no signi¢cant di¡er-
ence was observed between the two splice variants. The in-
ward single-channel conductance was 369 þ 11 (n = 12),
368 þ 2 (n = 7), 359 þ 10 pS (n = 5) for PCL, PCL-LV and
PCL-TS, respectively. At positive membrane potentials, both
PCL and splice variants exhibited smaller outward unitary
currents as compared to inward currents, partly due to the
presence of lower monovalent cation concentrations (V90
mM K and V20 mM Na) [35] and the presence of milli-
molar inhibitory Mg2 [36], the most abundant physiological
divalent cation within the cell. Water-injected and non-in-
jected control oocytes exhibited inward single-channel cur-
rents in 11 out of 45 patches under the same cell-attached
conditions, with a mean unitary conductance of 60 þ 10 pS
(n = 11). No values at positive potentials were calculated be-
cause less frequent outward openings (with small current am-
plitudes) were observed and hardly resolvable from back-
ground noise.
Fig. 3. Ca2-activated channel currents in oocytes expressing PCL-
LV or PCL-TS. A: Representative whole-cell current recordings
under voltage-clamp (350 mV). ‘Na+Ca’ = ‘Na’ plus 5 mM CaCl2.
‘1’, ‘2’ and ‘3’ indicate time points where the voltage ramp protocol
may be applied. B: I^V curves obtained under the basal (‘1’), Ca2-
activated (‘2’) and inactivated (‘3’) conditions. They were recorded
at the time corresponding to points 1, 2 and 3 indicated in A.
C: Ca2 activation of PCL-LV and PCL-TS in ‘NMDG+Ca’
(‘NMDG’ plus 5 mM CaCl2) at 350 mV.
Fig. 4. Ca2 activation ability of PCL and splice variant channels.
A: Averaged currents measured in ‘Na’ or ‘Na+Ca’ at 350 mV for
PCL (n = 32), PCL-TS (n = 46), PCL-LV (n = 46), and control
(water) (n = 23). B: The Ca2 activation ability was assessed by the
ratio of the whole-cell channel current in the presence of 5 mM
Ca2 to the one obtained without Ca2. ‘**’ on the PCL-LV bar
means that the ratio is very signi¢cantly larger (P6 0.01) than other
ratios.
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3.4. Functional properties of PCL C-terminal truncation
mutants
To determine how other parts of the C-terminal region
a¡ect the PCL function, we truncated PCL at various loca-
tions using site-directed mutagenesis. As illustrated (Fig. 1C),
the mutant T622X lacked most of the C-terminus, including
the EF-hand, while V670X, G692X and R740X all retained
the EF-hand. It turned out that all these mutants, like the
wild-type PCL, retained basal non-selective permeability to
monovalent (e.g. Na, Fig. 7A) and divalent cations (data
not shown), indicating that the C-terminus is not critical for
de¢ning basal channel activity. When evaluating the charac-
teristic ratio INaCa/INa, we found that the ratio was more
than two-fold larger for the mutant T622X (23.7 þ 4.1,
n = 32) than PCL (11.0 þ 1.0, n = 46), while those for V670X,
G692X and R740X were only modestly (though signi¢cantly)
di¡erent from PCL (13.9 þ 2.1, 7.1 þ 1.1, and 7.3 þ 1.1, n = 20,
17, and 21, respectively) (Fig. 7B). These data support the
observations obtained from our studies of the two splice var-
iants that removal of the EF-hand enhances the polycystin’s
Ca2 activation ability and that the C-terminus is not essential
for basal activity and Ca2-induced channel activation.
4. Discussion
Alternative splicing is a common phenomenon in many
human genes and constitutes an e⁄cient way to create diver-
sity using a minimum number of independent genes. It also
provides a mechanism to respond to tissue-speci¢c needs and
developmental regulations [24]. Splice variant channels have
often been shown to exhibit similar but distinct channel prop-
erties compared to their wild-type proteins [25,26]. However,
functional di¡erence between the wild-type and splice variants
is generally not well investigated. In the present study, we
have addressed the problem through functional studies of
two human PCL splice variants, PCL-LV and PCL-TS, iden-
ti¢ed from liver and testis, respectively. PCL-LV lacked the
EF-hand motif in its carboxyl segment and PCL-TS was a
protein shorter than PCL by 45 amino acids on the carboxyl
tail. We reported here that both splice variants retained a
basal conductance to cations in the absence of calcium, as
well as channel activation by calcium.
4.1. Endogenous channels in oocytes
Xenopus oocytes possess endogenous Cl3 channels that, like
PCL, can also be activated by calcium entry [37,38]. Our
previous studies showed that PCL channel activation persisted
in the absence of Cl3 (¢gure 4e in [19]). In the present study,
the average reversal potential of 320 mV obtained at activa-
tion peak under the approximately symmetrical Cl3 condition
was substantially di¡erent from the predicted value of 35 mV,
demonstrating that the majority of the observed current was
not due to Cl3 through endogenous channels. Interestingly,
C-terminal fragments of polycystin-1 were reported to up-reg-
ulate an endogenous cation channel in Xenopus oocytes [39].
This channel was non-selectively permeable to cations with a
unitary conductance of 20 pS in the presence of 100 mM Na,
much smaller than the one for PCL (150 pS, see [19]), and was
observed in control oocytes at a much lower probability. Fur-
thermore, PCL expressed in human embryonic kidney cells
was recently reported to display a similar basal unitary con-
ductance (in the presence of Na and absence of Ca2) to the
one obtained using oocytes [19,40], indicating that Xenopus
oocytes constitute an appropriate expression system for func-
tional studies of PCL.
4.2. Roles of the carboxyl-terminus in PCL basic functions
C-terminal deletions in the K-subunit of calcium channels
were reported to retain the channel function but result in
increased currents without signi¢cantly a¡ecting expression
levels [41]. Both of our splice variant channels displayed the
basal conductance to a number of mono- and divalent cations
in the absence of Ca2, including Na, K, Rb, Sr2, and
Ba2. Like PCL, they were impermeable to large cations such
as NMDG and choline and were inhibited by Mg2. With
respect to calcium-induced channel activation/inactivation,
the two splice channels exhibited characteristically similar re-
sponses to calcium entry following an extracellular calcium
application. Since PCL-LV does not possess a known calci-
um-binding motif, these results indicate that the EF-hand in
PCL is not essential for the channel activation and that the
action of Ca2 on the channel may be mediated through an
alternate mechanism. The results obtained from studies of
arti¢cial carboxyl-terminal truncation mutants were consistent
with those from the two splice variants. All four mutants
Fig. 5. Ca2-induced activation and inactivation time courses. The
half-rising time (tr) and half-decay time (td) obtained from each in-
ward current time course following calcium-induced activation.
A: The upper panel shows how the two parameters were de¢ned
and measured. Activation time course was characterized by tr (lower
panel). B: Inactivation time course was characterized by td. Shown
td and tr were averaged over various voltages ranging from 340 to
3140 mV.
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(T622X, V670X, G692X and R740X) retained the basal con-
ductance to Na and the capability of calcium-induced chan-
nel activation and ensuing inactivation. Our data together
demonstrated that the C-terminus is not crucial to these basic
functions of PCL. In particular, the EF-hand is not required
for calcium-induced channel activation/inactivation.
Despite the apparent similarity between PCL and the splice
variant channels in terms of basal conductance and calcium-
triggered activation, further examination revealed that their
Ca2-induced activation capability, assessed by the activation
ratio INaCa/INa, a parameter independent of channel expres-
sion level, di¡ered substantially from each other. The four
arti¢cial truncation mutants also exhibited di¡erent activation
ratios. PCL-LV and T622X, both lacking the EF-hand motif,
were associated with two- to three-fold higher activation ra-
tios than those possessing the motif, indicating that the motif
may have a modulation e¡ect on the channel activation. It is
possible that calcium ion binds to the motif in order to reg-
ulate PCL function and prevent it from over-activation. It is
still unclear what is the physiological a⁄nity of the motif for
calcium-binding and why liver would not need such a regu-
lation of channel activation.
Whether the EF-hand motif links to channel inactivation in
the super family of cation channels possessing six transmem-
brane domains is still controversial. For example, Zhou and
colleagues reported that the motif is not responsible for the
calcium-induced feedback inactivation in the K1C-subunit [30]
that shares a common membrane topology and modest se-
quence similarity with PCL. However, other reports have
demonstrated that the motif is indeed involved in the channel
inactivation process [27^29]. In the case of PCL, although we
did not observe a direct involvement of the consensus Ca2-
binding EF-hand in channel inactivation, the augmented acti-
vation ratio might be the result of reduced inactivation ability.
Thus, although the motif is not essential for channel activa-
tion/inactivation, it clearly exhibited modulation roles in the
processes.
4.3. Comparison with PC2
Despite the high similarity between PCL and PC2 in amino
Fig. 6. Single-channel currents of PCL-LV and PCL-TS under the cell-attached con¢guration. A: Representative recordings in oocytes express-
ing one or another splice variant. The oocyte chamber contained the Barth’s solution. Membrane potential was applied from the pipette and
was indicated on each recording. Inward (downward) currents were carried by cations of the pipette solution while outward currents were car-
ried by oocyte endogenous cations. B: I^V relationships for PCL, the two splice variants, and oocyte endogenous channels.
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acid sequence and membrane topology, they substantially dif-
fered in single-channel conductance (290 vs. 120 pS with 100
mM K and 150 vs. 23 pS with 100 mM Na). Since there is
about 20-fold more extracellular Na than K, the entry of
Na through PCL should be predominant at physiological
(negative) potentials (e.g. 350 mV) despite of the two-fold
higher conductance for K. The membrane targeting informa-
tion seems to be contained in di¡erent segments of PCL and
PC2. Our present study and that led by Dr. Somlo [42] sug-
gest that membrane targeting of PCL is not determined by its
C-terminus. In contrast, the PC2 C-terminus appeared to be
responsible for this process. A PC2 pathogenic truncation mu-
tant lacking the major part of the C-terminus, named R742X,
expressed predominantly in oocyte plasma membrane while
the wild-type was mostly localized in intracellular organelles
[23]. Expression of PC2 in CHO cells resulted in its predom-
inant localization in intracellular organelles as well while its
co-expression with polycystin-1 resulted in its targeting to the
plasma membrane [22]. This later study demonstrated that the
PC2 C-terminus is important for both membrane targeting
and formation of a functional complex with polycystin-1 in
the plasma membrane. However, the membrane localization
of PC2 has rather been controversial [20,43,44]. Although
there has been no reported controversy regarding PCL sub-
cellular localization, much work has yet to be done in order to
elucidate the PCL domains involved in calcium-induced acti-
vation and membrane targeting.
Although there is no other Ca2-binding motif in PCL, it is
still possible that calcium binds to another site in PCL to
trigger the activation. It was recently reported that a PCL
splice variant cloned from human brain lacking part of the
N-terminus targeted to intracellular compartments of CHO-
K1 cells and resulted in loss of channel function when ex-
pressed in oocytes [42]. Deletion of the entire N-terminus of
PCL resulted in the complete loss of channel activity in oo-
cytes (Li et al., unpublished data). On the other hand, it is
possible that the observed channel activation is not due to a
direct association between Ca2 and PCL at all. This would
mean that there exists an intermediate Ca2-binding protein
subunit which associates with PCL to mediate channel activa-
tion. Upon association, the PCL^subunit complex would
undergo conformational changes triggered by calcium-binding
to the subunit, which then results in activation.
While removal of the putative Ca2-binding EF-hand motif
in the carboxyl tail of PCL resulted in the observed increase in
activation capability, it remains to be elucidated which resi-
dues in the motif are responsible for the increase. An alter-
natively spliced isoform of a voltage-gated channel, missing
the EF-hand motif, has previously been identi¢ed in rat hip-
pocampal neurons [24]. This splice variant was shown to be
developmentally regulated in a way di¡erent from the wild-
type. Thus, it will be of great importance to clarify how PCL-
LV and PCL protein (if present) in liver might be develop-
mentally regulated, and why liver needs such altered channel
functions.
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